French cosmetic ingredients maker Sweetch has acquired compatriots Laboratoire Greenpharma, an R&D specialist in natural active ingredients, phytochemistry and green extraction technologies.
Orléans-based Laboratoire Greenpharma’s capabilities will be integrated into Sweetch’s R&D pipeline to accelerate the development of new cosmetic actives and strengthen scientific substantiation and claims support.
Sweetch said the acquisition would strengthens its position in the global cosmetic ingredient market by expanding its active ingredients portfolio and reinforcing its end-to-end innovation capabilities, from ingredient discovery to objectivated performance and responsible sourcing.
By combining its expertise in microbiome technologies, delivery systems, and sustainable formulation with Greenpharma’s advanced scientific infrastructure, Sweetch aims to provide cosmetic brands with accelerated access to validated, high-performance natural ingredients.
CEO Cyril Gallardo said Greenpharma immediately enhances Sweetch’s innovation ecosystem.
“The chemoinformatic platform and extensive proprietary database allow unequalled ingredient selection and accelerated development,” he added.
“These unique tools, combined with state-of-the-art extraction technologies, including supercritical CO₂, a sophisticated analytical laboratory, and green chemistry capabilities, form an outstanding, industry-leading innovation ecosystem.”
French private equity outfit Ekkio Capital established Sweetch in July 2024 via a trio of acquisitions.
Dutch skin microbiota specialist Gobiotics, French delivery systems maker Creathes, and CreaChem, a Belgian producer of saccharides from chicory roots, beet roots and rice, united under the Sweetch umbrella.
From the perspective of Laboratoire Greenpharma, the acquisition reflects strong alignment in values and long-term vision.
“The values of both companies are aligned in terms of human and scientific values. We have a complementary catalogue considering products and services. That is why synergies will be present at different levels,” said Philippe Bernard, founder of Laboratoire Greenpharma.
“Furthermore, we will gain increased visibility both locally and internationally. The group will acquire the momentum to face the challenges of the cosmetic industry of the future.”
Laboratoire Greenpharma will bring its scientific and technical expertise in natural products, as well as cutting-edge technologies such as integrated AI in the R&D process, added Bernard.
“We also have a strong R&D service activity to address the specific needs of customers, for example in the development of exclusive active ingredients.
“Finally, Laboratoire Greenpharma has also worked for other industries and can contribute to expanding activities into additional sectors.”
